EUR/USD 1.15960
0.244%
Gold 4394.14
0.412%
Oil 81.611
0.155%
USD/JPY 159.142
-0.134%
GBP/USD 1.35508
0.122%
GBP/JPY 215.655
-0.013%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On August 17, Iranian Foreign Ministry spokesman Baghae stated that the environmental damage caused by the continued US military presence in the region has resulted in trillions of dollars in losses, and Iran will prioritize seeking compensation for these losses. Baghae claimed that the environmental damage caused by the US in the Persian Gulf and the Gulf of Oman is not limited to the past six months or year, but has continued for approximately 50 years. The US military presence, accompanied by the use of advanced weaponry, numerous military exercises, and various wars waged in the region, has caused enormous environmental damage, resulting in trillions of dollars in losses. Baghae stated that this damage has been further exacerbated in the past two years due to the attacks on various facilities along the Persian Gulf coast by the US and Israel, as well as the consequences of their military presence. Iran will definitely prioritize seeking compensation for these damages.On August 17th, Geely Automobile (00175.HK) announced that Li Shufu will resign as Chairman of the Board and Executive Director of Geely Automobile Holdings Limited, effective August 18, 2026. In recognition of his outstanding contributions to the companys development over the years, he has been appointed as Honorary Chairman for Life. As a major and controlling shareholder, he will continue to fully support the companys long-term development. Li Shufu will continue to serve as Chairman of Zhejiang Geely Holding Group. An Conghui has been appointed Chairman of the Board of Directors of Geely Automobile Holdings Limited. Li Donghui has resigned as Vice Chairman of the Board of Directors of Geely Automobile Holdings Limited but will continue to serve as an Executive Director. Gui Shengyue has resigned as CEO of Geely Automobile Holdings Limited but has been appointed as Vice Chairman of the Board of Directors and will continue to serve as an Executive Director, in order to improve the efficiency of communication and coordination between the Board and management. Gan Jiayue has been appointed CEO of Geely Automobile Holdings Limited, responsible for the companys daily operations.According to Hong Kong Stock Exchange filings, HSBC Holdings (00005.HK) spent HK$19.9 million to repurchase 1.3 million shares on August 14.Iranian Foreign Ministry spokesman Baghae: Fundamentally, the problem between us and the United States is not about mediation; the problem lies in the American way of thinking, its misjudgments, and its clinging to methods and means that have been proven to fail countless times, while the US administration continues to repeat the same mistakes. The result will inevitably be no different from the past.Iranian Foreign Ministry spokesman Bagaei: Admitting mistakes can be a prerequisite for making the right decisions, but I doubt whether US policymakers have that courage.

U.S. Restricts Use of J&J's COVID Vaccine Due to Risk of Blood Clots

Charlie Brooks

May 06, 2022 09:38

J2.png


The US Food and Drug Administration said on Thursday that it will restrict adult use of Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccination owing to the danger of a rare blood clotting condition, the latest setback for the injection that has been supplanted by competitors.


The J&J shot, which was cleared for adult use in the United States in February 2021, may be used in situations when permitted or approved COVID-19 vaccinations are unavailable or if an user is averse to receiving the other two doses, the Food and Drug Administration said.


J&J is one of three vaccinations that are now in use in the United States. The remaining two are from Moderna (NASDAQ:MRNA) and Pfizer, respectively (NYSE:PFE).


The vaccine manufacturer said that it has amended the COVID-19 vaccination information sheet for the United States to include a warning regarding the risk of thrombosis associated with thrombocytopenia syndrome (TTS), an uncommon but potentially fatal illness.


In high-income nations, use of the J&J shot has been limited, owing to reports of rare, possibly fatal blood clots, manufacturing difficulties, including an unintentional component mix-up by a contract manufacturer, and doubts about effectiveness.


The manufacturer revised its projection for COVID-19 vaccine sales last month, citing a supply glut.


TTS, which is characterized by blood clots and a low platelet count, has previously been documented in recipients of the J&J vaccination.


The FDA changed the information sheet for the J&J vaccine in January to reflect the risk of immune thrombocytopenia, after months of similar action by the European Union's medicines authority.


The FDA stated Thursday that after conducting a study into reported instances, the risk of TTS justified restricting the use of the single-dose injection.


In December, the US Centers for Disease Control and Prevention suggested that Americans take mRNA doses from Pfizer or Moderna rather than J&J's vaccination owing to the possibility of blood clotting.


According to the CDC, about 18.7 million Americans got a J&J COVID-19 injection, compared to 217.5 million who received the Moderna vaccination and 340.6 million who received the Pfizer shot.

Suggestion